Pharma Focus Asia

Glenmark Pharma gets ANDA approval for nebivolol tablets

Monday, May 29, 2017

Glenmark Pharmaceuticals Ltd Says receives ANDA approval for nebivolol tablets, 2.5 mg, 5 mg, 10 mg and 20 mg.

Co may be eligible for 180 days of generic drug exclusivity for nebivolol tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg.

magazine-slider-imageMFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024INALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024ISPE Singapore Affiliate Conference & Exhibition 2024Rehab Expo 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024LogiPharma Asia 2024